Neuronetics (STIM) Capital Expenditures Growth (3y) (2020 - 2026)
Neuronetics (STIM) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 2.15% |
| 10 | Neuronetics | 118.30 Mn | 112.29 Mn | 16.15 Mn | -5.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.58% |
| Dec 31, 2025 | -24.56% |
| Sep 30, 2025 | -7.26% |
| Jun 30, 2025 | -26.79% |
| Mar 31, 2025 | -65.79% |
| Dec 31, 2024 | -26.57% |
| Sep 30, 2024 | 43.80% |
| Jun 30, 2024 | -26.38% |
| Mar 31, 2024 | 4.13% |
| Dec 31, 2023 | 38.21% |
| Sep 30, 2023 | -46.23% |
| Jun 30, 2023 | 273.93% |
| Mar 31, 2023 | 35.53% |
| Dec 31, 2022 | -13.68% |
| Sep 30, 2022 | 242.94% |
| Jun 30, 2022 | 221.28% |
| Mar 31, 2022 | 190.08% |
| Dec 31, 2021 | 91.76% |
| Sep 30, 2021 | -92.94% |
| Jun 30, 2021 | 62.22% |